To further investigate the role of the PI3K/mTOR pathway in shaping the TME in (u)LMS, we pursued tumour immune‐landscape mapping according to the six pan‐cancer immune landscapes identified by Torsson et al.35 This evidence concerns the gene PIK3CB and neoplasm.